Patent Cooperation Treaty (PCT)

International patent application treaty enabling single-application patent filing in 150 plus countries.

Definition

Patent Cooperation Treaty (PCT) is an international patent treaty enabling single PCT application that can be extended to 150 plus member countries within 30 months. Administered by WIPO.

Context

Delaware LLCs with novel inventions can use PCT for global patent protection strategy.

Example

A Delaware LLC files US patent application, then files PCT application within 12 months. PCT designation allows up to 30 months to enter national-phase patents in specific countries.

Common pitfalls

High costs for national-phase entries.
Strict deadlines (12-month priority, 30-month national phase).
Engage patent attorney for any PCT strategy.

What the Patent Cooperation Treaty Actually Does for a Delaware LLC

The Patent Cooperation Treaty is best understood as a procedural bridge rather than a grant of rights. When a Delaware LLC owned by a non-US founder files a single international application under the treaty, that filing does not produce a worldwide patent. There is no such thing. Instead, the filing reserves a place in line across the treaty's member states and buys time before the founder has to commit money to individual country filings. For a small company that has just been formed and is still proving its product, that time is the real asset. It lets the business test markets before deciding where patent protection is worth paying for.

For a founder running a single-member foreign-owned LLC, the practical sequence usually starts with a US national application, then a treaty application claiming priority back to that first filing. The treaty application does not replace national patents. It simply keeps the option open to pursue them later in chosen jurisdictions. This is why the treaty is described as a strategy tool. The LLC is the named applicant on the paperwork, which keeps ownership clean and attached to the entity rather than scattered across the founder's personal name and the company.

Because the treaty is administered by the World Intellectual Property Organization, the same set of rules applies regardless of where the founder personally resides. A founder in Lagos, Karachi, or Manila who owns a Delaware LLC files under the same framework as a founder in California. The entity's place of formation, Delaware, does not by itself confer or restrict treaty access. What matters is that the applicant qualifies as a national or resident of a member state, and US-formed entities generally do.

Why an Early-Stage Non-Resident Founder Might Care

Most non-resident founders forming a Delaware LLC are building software, ecommerce brands, or service businesses where patents are not the center of gravity. For them the treaty is background knowledge they may never act on, and that is a perfectly reasonable outcome. The founders who should pay attention are those with a genuine technical invention. That includes a novel hardware device, a manufacturing process, a chemical formulation, or in some cases a specific technical method that solves a problem in a non-obvious way. If the invention is the moat, then preserving the ability to patent it across markets has real commercial weight.

The reason the treaty matters early is timing. Patent rights are tied to strict priority dates, and public disclosure can destroy the ability to patent in many countries. A founder who launches a product, posts a detailed teardown online, and only thinks about patents a year later may find the door has already closed in several jurisdictions. Understanding the treaty before launch helps the founder sequence disclosure and filing in the right order. The entity formation step and the intellectual property step are connected, even though they feel like separate tasks.

There is also a fundraising angle. Investors who back deep-technology companies often ask about patent posture during diligence. A treaty application on file signals that the founder has thought about protecting the invention across markets without yet spending heavily on national filings. It is not a guarantee of value, but it is a credible signal that the company treated its core technology as an asset worth defending.

How the Single-Member Foreign-Owned LLC Fits In

A single-member LLC owned by a non-US person is, by default, treated as a disregarded entity for US federal tax purposes. That tax classification does not change how the company holds intellectual property. The LLC is still a legal person capable of owning patents, applications, trademarks, and contracts in its own name. So when the founder files a treaty application, the LLC can be listed as the applicant and the eventual owner of any national patents that issue, keeping the asset attached to the business rather than to an individual.

This separation matters when the founder later wants to raise money, sell the business, or license the technology. If the patent rights sit inside the LLC, a buyer or licensee deals with the entity directly. If the rights sit in the founder's personal name, every transaction needs a separate assignment from the individual, which complicates diligence and can stall deals. Naming the LLC as applicant from the start avoids that friction. The inventor named on the application is still the human who created the invention, because only natural persons can be inventors, but ownership can be assigned to the company.

There is a documentation point that founders often miss. The LLC needs a written assignment from the inventor to the company, even when the inventor and the sole member are the same person. That assignment is what actually moves legal title from the human inventor to the entity. Without it, ownership can be ambiguous, which undermines the whole reason for filing in the company's name. General information here is not a substitute for a patent attorney drafting the assignment correctly.

A Worked Example From Formation Through Filing

Consider a founder in Nairobi who has designed a low-cost water filtration cartridge. She forms a Delaware LLC by filing the Certificate of Formation for $110 and obtains an EIN by submitting Form SS-4, which for a non-resident without a Social Security number typically takes around 8 to 10 business days to process. With the entity and EIN in place, she opens a US business account with a provider such as Mercury or Wise so the company can pay filing fees and vendors in dollars.

Before any public launch, she works with a patent attorney to file a US national application naming herself as inventor and the LLC as applicant, supported by a written assignment of rights to the company. This first filing establishes her priority date. Within 12 months of that date she files a treaty application that claims priority back to it. That treaty step does not create patents abroad. It preserves her ability to enter the national phase in selected countries within the 30-month window measured from the priority date.

During those months she sells the cartridge in a few markets, learns where demand is real, and decides she only needs protection in three countries plus the US. At national-phase entry she pays the separate filing, translation, and attorney costs for just those jurisdictions rather than all 150 plus. Meanwhile her LLC keeps meeting its ordinary obligations, including the $300 flat franchise tax due each year on June 1 and its federal information filings. The intellectual property track and the entity-maintenance track run in parallel.

Connecting the Treaty to Banking and Money Movement

Patent work is expensive, and the costs arrive in waves across years and currencies. The first US filing, the treaty filing, and each national-phase entry all carry their own fees, and many are billed by foreign agents in local currency. A non-resident founder who runs payments through a US business account designed for international founders, such as Wise, Payoneer, or Relay, can handle these cross-border payments without constant friction. Keeping the spending inside the company account also keeps the paper trail clean, which matters for both tax records and any future investor diligence.

Treating patent costs as company expenses rather than personal spending reinforces the ownership structure described earlier. When the LLC pays the patent attorney and the foreign agents directly, the invoices, assignments, and filings all point to the same legal owner. That consistency makes it far easier to demonstrate, years later, that the company and not the founder personally controls the rights. A scattered trail where some fees came from a personal card and others from the business account creates exactly the ambiguity that buyers and licensees dislike.

Banking choice also affects practical timing. National-phase deadlines under the treaty are firm, and a missed wire because an account was frozen or a transfer bounced can have consequences that money cannot easily fix. Founders sometimes underestimate how a banking hiccup, common for new international accounts, can collide with a hard legal deadline. Building a small buffer of funds in the company account ahead of known deadlines is a sensible operational habit, not a legal requirement.

How It Relates to the Company's Tax and Reporting Duties

A foreign-owned single-member LLC has specific US reporting obligations that exist independently of any patent activity, and founders should not let intellectual property work distract from them. The central one is Form 5472 filed together with a pro forma Form 1120, which reports transactions between the LLC and its foreign owner. The penalty for failing to file is $25,000, so this is a filing that gets treated as non-optional in practice. Patent-related money movement can itself be a reportable transaction, which is one more reason to keep clean records of who paid what.

When the founder funds the LLC to cover patent filing fees, that capital contribution is generally a reportable transaction between the foreign owner and the disregarded entity. The same is true if the company later distributes money back to the owner from licensing income. None of this is unique to patents, but the treaty timeline tends to generate exactly these kinds of cross-border transfers across multiple years. Recording each one as it happens makes the annual Form 5472 far less painful to assemble.

If the company eventually earns licensing royalties from patents that issue, the tax picture grows more involved and can pull in withholding rules and treaty questions of a different kind, the income-tax kind, which are unrelated to the patent treaty despite the shared word. At that stage the founder genuinely needs professional tax advice. This general information cannot tell any specific founder how royalty income will be taxed in their situation, because that depends on facts the founder must work through with an advisor.

The BOI Reporting Picture Around the Same Time

Founders often bundle every compliance worry together, so it helps to separate beneficial ownership reporting from patent matters. Under the FinCEN Interim Final Rule issued on March 26, 2025, US-formed entities such as a Delaware LLC are exempt from the beneficial ownership information reporting that had previously been expected. That means a domestic Delaware LLC owned by a non-resident does not, under that rule, file the BOI report that many founders had braced for. This is a reporting question about company ownership transparency and has nothing to do with the patent treaty.

The reason it is worth mentioning here is sequencing and peace of mind. A founder setting up a Delaware LLC to hold an invention can cross BOI off the worry list for a US-formed entity and focus attention on the filings that do apply, namely the federal income and information returns and the state franchise tax. Reducing the number of perceived obligations makes it easier to give the patent timeline the careful attention its hard deadlines demand.

Rules in this area have shifted more than once, so a founder should confirm the current state of beneficial ownership reporting for their specific entity type rather than assuming an exemption is permanent. The point for treaty planning is narrow. Patent filings and beneficial ownership reporting are governed by entirely different agencies and frameworks, and progress on one does not satisfy the other.

The Priority Date and Why Twelve Months Is the Hinge

The single most important concept tied to the treaty is the priority date. When the founder files that first national application, the date of filing becomes the reference point against which novelty is judged worldwide. Everything in the treaty timeline counts from that date. The well-known 12-month window is the period within which a treaty application must be filed in order to claim the benefit of that original priority date. Miss the window and the founder loses the ability to anchor later filings to the earlier date, which can be fatal if the invention has been disclosed in the meantime.

This is where founders most often get into trouble, because product timelines and patent timelines do not naturally align. A startup wants to launch, demo, and sell as fast as possible, while patent strategy rewards careful control of disclosure before key dates. A founder who files the first application, then spends the next 11 months heads-down on the product, can let the 12-month deadline slip simply because no one was tracking it. The remedy is to put both the 12-month and the later 30-month dates on a calendar the moment the first application is filed.

The 30-month figure, measured from the priority date, is the typical deadline for entering the national phase in chosen countries. Some jurisdictions use a slightly different period, which is one of the edge cases discussed below. Treating these as soft targets is a common and costly mistake. They behave like hard walls, and patent offices rarely show flexibility once a deadline has passed.

Worked Example of a Disclosure Mistake

Picture a founder who builds a clever electronic dimmer module and forms a Delaware LLC to commercialize it. Excited about traction, he posts a detailed engineering breakdown on a public forum, including schematics, three weeks before filing any patent application. In the United States there is a limited grace period for an inventor's own disclosures, so a US filing may still be possible within a set window. In many other countries, however, that public disclosure is an absolute bar. The invention is no longer considered new, and no treaty filing can undo a disclosure that already happened.

The damage is uneven across the map, which makes it confusing. The founder might still secure a US patent while having permanently lost the ability to patent the same invention in several markets he cared about. The treaty cannot rescue rights that were extinguished by disclosure before the priority date was established. This is why the ordering of launch announcements, demos, and filings is a strategic decision and not just a marketing schedule.

The lesson for a non-resident founder is to involve a patent attorney before, not after, any public reveal of a patentable invention. The cost of an early consultation is small compared with losing protection in a target market. General information like this can flag the risk, but only a qualified attorney can advise on whether a specific disclosure has compromised specific rights, because the answer depends on dates, wording, and the countries involved.

National-Phase Entry and Where the Real Money Goes

The treaty application is comparatively affordable next to what comes after it. The expensive phase is national entry, when the founder must pursue an actual patent in each individual country. Each entry can require local filing fees, translation into the local language, and a local agent or attorney to prosecute the application through that country's patent office. Multiply that across several jurisdictions and the costs climb quickly, which is exactly why the treaty's deferral of these costs is so valuable to a cash-conscious startup.

This cost structure shapes strategy. A founder rarely enters all 150 plus member states. Instead the company picks the markets where it manufactures, sells, or faces credible competitors, and concentrates spending there. The months between the treaty filing and national entry are meant to be used for exactly this triage, gathering market data so the eventual country list reflects commercial reality rather than guesswork. A Delaware LLC that has been selling for a year has far better information for that decision than it did at first filing.

Because translation and local-agent costs vary widely by country, founders should budget conservatively and avoid assuming a uniform per-country figure. Some jurisdictions are inexpensive to enter, others are not. The point is that national-phase entry is a series of separate commitments, each with its own cost and deadline, rather than a single global payment. Planning the company's cash flow around those staggered commitments is part of using the treaty well.

Related Terms and How They Interlock

The treaty sits near several related concepts that a founder will encounter. Work for hire is one, because it governs who owns inventions and creative output produced by people the company pays. If a contractor or employee develops part of the invention, the company needs the rights assigned to it, otherwise the ownership the founder assumed may not actually rest with the LLC. A treaty application is only as solid as the chain of ownership beneath it, and that chain runs through assignment and work-for-hire arrangements.

Trademarks are a separate track that founders sometimes confuse with patents. A trademark protects a brand name or logo, while a patent protects an invention. They are filed under different systems and follow different international frameworks, and progress on one does not protect the other. A founder with both a novel product and a distinctive brand needs to think about each separately, even though both are company assets held by the LLC.

Inventorship and ownership are distinct as well. Only a natural person can be an inventor, and inventorship is a question of fact about who conceived the invention. Ownership, by contrast, can be transferred to the company by assignment. A founder who treats these as interchangeable can create errors on the application that are awkward to fix later. Keeping the inventor designation accurate while assigning ownership to the LLC is the clean approach.

Edge Cases Founders Run Into

One edge case is the country whose national-phase deadline differs from the common 30-month figure. A handful of jurisdictions use a different period, and a founder who applies the standard number everywhere can miss a shorter deadline in a country that matters. The reverse also happens, where a longer window exists, but relying on it without confirmation is risky. The safe practice is to confirm each target country's specific deadline rather than assuming uniformity.

Another edge case involves multiple inventors who live in different countries. If two people jointly created the invention and one resides outside the treaty's member states, eligibility and assignment can get more complicated. The usual fix is that as long as at least one applicant qualifies, the filing can proceed, but the details depend on the specific facts. A single-member LLC with one founder-inventor avoids most of this, which is part of why the simple structure is attractive for first-time founders.

A third edge case is the founder who forms the Delaware LLC after already filing a patent application in their personal name. Moving those rights into the company later is possible through assignment, but it adds a step and a document that must be executed correctly and recorded. Forming the entity first and filing in its name from the start is cleaner. When the order gets reversed, the founder should treat the assignment as a priority rather than an afterthought, ideally with a patent attorney's help.

Common Misunderstandings to Avoid

The most widespread misunderstanding is that a treaty application is itself a patent. It is not. It is a unified procedure that preserves the option to seek patents in many countries, and it produces no enforceable patent on its own. A founder who believes they hold a worldwide patent because they filed once under the treaty may make business decisions on a false premise, such as confronting a competitor over rights that have not actually issued anywhere yet.

A second misunderstanding is that forming a Delaware LLC somehow grants or strengthens patent rights. The entity is the owner and the applicant, and it provides a clean home for the asset, but Delaware formation does not create intellectual property or improve a patent's chances. Patentability turns on whether the invention is new, useful, and non-obvious, judged against everything publicly known. The state of formation is irrelevant to that question.

A third misunderstanding is that patents are necessary for every startup. Many successful non-resident-owned LLCs never file a single patent because their advantage lies in brand, execution, distribution, or service rather than a protectable invention. Spending limited early capital on patent filings for a business whose moat is not technical can be a poor allocation. The treaty is a powerful option for the companies that need it and an unnecessary expense for those that do not. This is general information and not legal or tax advice, and a founder weighing patent strategy should consult a qualified patent attorney about their specific invention and markets.

Related terms

Work for hire

Related glossary terms & guides

Form your LLC WhatsApp

WhatsApp Form your LLC